MCID: DNT012
MIFTS: 53

Dental Caries

Categories: Gastrointestinal diseases, Oral diseases

Aliases & Classifications for Dental Caries

MalaCards integrated aliases for Dental Caries:

Name: Dental Caries 12 74 54 43 15 17 71 32
Dental Caries Extending into Pulp 12
Dental Caries of Smooth Surface 12
Dental Caries Pit and Fissure 12
Smooth Surface Dental Caries 17

Classifications:



External Ids:

Disease Ontology 12 DOID:216
ICD9CM 34 521.0 521.07
MeSH 43 D003731
NCIt 49 C52593
SNOMED-CT 67 80967001
ICD10 32 K02 K02.6 K02.9
UMLS 71 C0011334 C1456145

Summaries for Dental Caries

Disease Ontology : 12 A teeth hard tissue disease that is characterized by damage to a tooth that can happen when decay-causing bacteria in your mouth make acids that attack the tooth’s surface, or enamel.

MalaCards based summary : Dental Caries, also known as dental caries extending into pulp, is related to dentin caries and root caries, and has symptoms including snoring and halitosis. An important gene associated with Dental Caries is TFIP11 (Tuftelin Interacting Protein 11), and among its related pathways/superpathways is Salivary secretion. The drugs Sorbitol and Ethanol have been mentioned in the context of this disorder. Affiliated tissues include testes, salivary gland and bone, and related phenotypes are Decreased hepcidin::fluc mRNA expression and Decreased viability

Wikipedia : 74 Tooth decay, also known as dental caries or cavities, is a breakdown of teeth due to acids made by... more...

Related Diseases for Dental Caries

Diseases related to Dental Caries via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 298, show less)
# Related Disease Score Top Affiliating Genes
1 dentin caries 34.0 STATH DSPP
2 root caries 33.7 STATH LTF DSPP
3 enamel caries 33.1 TUFT1 STATH ENAM AMELX AMBN
4 dental fluorosis 31.6 TUFT1 ENAM DSPP AMELX AMBN
5 gingival recession 30.9 DSPP AMBN
6 capgras syndrome 30.7 PRH2 PRH1
7 dental pulp necrosis 30.6 DSPP AMELX
8 hypoplastic amelogenesis imperfecta 30.5 ENAM AMBN
9 amelogenesis imperfecta 30.1 TUFT1 ENAM DSPP AMELX AMBN
10 calvarial doughnut lesions with bone fragility 11.4
11 aplasia of lacrimal and salivary glands 11.4
12 epidermolysis bullosa dystrophica, autosomal dominant 11.3
13 flynn-aird syndrome 11.3
14 johnson neuroectodermal syndrome 11.3
15 cockayne syndrome a 11.3
16 cutis laxa, autosomal recessive, type iia 11.3
17 insensitivity to pain, congenital, with anhidrosis 11.3
18 osteopetrosis, autosomal recessive 1 11.3
19 timothy syndrome 11.3
20 cockayne syndrome 11.3
21 periapical granuloma 11.3
22 periapical periodontitis 11.3
23 benjamin syndrome 11.3
24 recessive dystrophic epidermolysis bullosa-generalized other 11.3
25 odontoclasia 11.0
26 gingivitis 10.9
27 periodontitis 10.8
28 body mass index quantitative trait locus 1 10.7
29 down syndrome 10.6
30 cerebral palsy 10.5
31 dentine erosion 10.5 TUFT1 TFIP11
32 body mass index quantitative trait locus 11 10.5
33 body mass index quantitative trait locus 9 10.5
34 body mass index quantitative trait locus 8 10.5
35 body mass index quantitative trait locus 4 10.5
36 body mass index quantitative trait locus 10 10.5
37 body mass index quantitative trait locus 7 10.5
38 body mass index quantitative trait locus 12 10.5
39 body mass index quantitative trait locus 14 10.5
40 body mass index quantitative trait locus 18 10.5
41 body mass index quantitative trait locus 19 10.5
42 body mass index quantitative trait locus 20 10.5
43 dental pulp calcification 10.5 ENAM DSPP
44 pulpitis 10.5
45 amelogenesis imperfecta, type ic 10.5 ENAM AMELX
46 chronic ethmoiditis 10.5 MUC7 MUC5B
47 cleft lip 10.5
48 pulp degeneration 10.5 DSPP AMBN
49 hair whorl 10.4
50 rickets 10.4
51 diabetes mellitus 10.4
52 granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i 10.4 PRH2 PRH1
53 palmoplantar keratoderma, nonepidermolytic, focal or diffuse 10.4 TUFT1 AMELX
54 acute apical periodontitis 10.4 STATH HTN1
55 suppurative periapical periodontitis 10.4 DSPP AMBN
56 iron metabolism disease 10.4
57 47,xyy 10.4
58 cleft lip/palate 10.4
59 rapidly involuting congenital hemangioma 10.4
60 amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 2 10.4 TUFT1 ENAM AMBN
61 anxiety 10.4
62 trichodentoosseous syndrome 10.4 ENAM DSPP AMBN
63 amelogenesis imperfecta, type ib 10.4 ENAM AMBN
64 dentin dysplasia 10.4 ENAM DSPP AMBN
65 amelogenesis imperfecta, type ie 10.4 TUFT1 AMELX AMBN
66 enamel erosion 10.4 STATH CA6 AMELX
67 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.4
68 tooth resorption 10.4 DSPP AMELX AMBN
69 attention deficit-hyperactivity disorder 10.3
70 dental pulp disease 10.3 DSPP AMELX
71 amelogenesis imperfecta, type iiia 10.3 ENAM AMELX AMBN
72 cleft palate, isolated 10.3
73 asthma 10.3
74 gingival disease 10.3
75 hyperglycemia 10.3
76 hypercementosis 10.3 ENAM DSPP AMELX AMBN
77 allergic rhinitis 10.3
78 alacrima, achalasia, and mental retardation syndrome 10.3
79 endocarditis 10.3
80 bacterial infectious disease 10.3
81 rhinitis 10.3
82 mastitis 10.3 LTF LPO CSN1S1
83 bone benign neoplasm 10.2 AMELX AMBN
84 osteoporosis 10.2
85 autism 10.2
86 cystic fibrosis 10.2
87 ocular motor apraxia 10.2
88 periodontitis, chronic 10.2
89 sjogren syndrome 10.2
90 bone mineral density quantitative trait locus 8 10.2
91 bone mineral density quantitative trait locus 15 10.2
92 joint laxity, short stature, and myopia 10.2
93 deficiency anemia 10.2
94 infective endocarditis 10.2
95 myopia 10.2
96 oral candidiasis 10.2
97 candidiasis 10.2
98 periodontosis 10.2
99 autosomal recessive hypophosphatemic rickets 10.2 STATH DSPP
100 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.2
101 autism spectrum disorder 10.2
102 rheumatic fever 10.2
103 poliomyelitis 10.2
104 lupus erythematosus 10.2
105 colorectal cancer 1 10.2 MUC7 MUC5B
106 tooth erosion 10.2 STATH ENAM DSPP CA6 AMELX
107 tooth agenesis 10.1 TUFT1 ENAM DSPP AMELX AMBN
108 craniofacial-deafness-hand syndrome 10.1
109 otitis media 10.1
110 immune deficiency disease 10.1
111 helicobacter pylori infection 10.1
112 leukemia, acute lymphoblastic 10.1
113 orofacial cleft 10.1
114 inflammatory bowel disease 10.1
115 immunoglobulin alpha deficiency 10.1
116 thalassemia 10.1
117 heart disease 10.1
118 iron deficiency anemia 10.1
119 protein-energy malnutrition 10.1
120 allergic hypersensitivity disease 10.1
121 diarrhea 10.1
122 epidermolysis bullosa 10.1
123 pulmonary tuberculosis 10.1
124 kidney disease 10.1
125 chronic kidney disease 10.1
126 collagen disease 10.1
127 neurofibromatosis 10.1
128 learning disability 10.1
129 stomatitis 10.1
130 chromosomal triplication 10.1
131 leukoplakia 10.1
132 nephronophthisis 3 10.1 PRH2 PRH1
133 atherosclerosis susceptibility 10.0
134 gastroesophageal reflux 10.0
135 multiple sclerosis 10.0
136 hand skill, relative 10.0
137 systemic lupus erythematosus 10.0
138 rheumatoid arthritis 10.0
139 diabetes mellitus, type i 10.0
140 schopf-schulz-passarge syndrome 10.0
141 fructose intolerance, hereditary 10.0
142 tooth size 10.0
143 ataxia and polyneuropathy, adult-onset 10.0
144 coronary heart disease 1 10.0
145 human immunodeficiency virus type 1 10.0
146 graft-versus-host disease 10.0
147 mulchandani-bhoj-conlin syndrome 10.0
148 bone resorption disease 10.0
149 pre-eclampsia 10.0
150 goiter 10.0
151 quadriplegia 10.0
152 cholera 10.0
153 hemangioma 10.0
154 iga glomerulonephritis 10.0
155 liver cirrhosis 10.0
156 acquired immunodeficiency syndrome 10.0
157 actinomycosis 10.0
158 crohn's disease 10.0
159 diabetic neuropathy 10.0
160 hemophilia 10.0
161 growth hormone deficiency 10.0
162 oral cancer 10.0
163 headache 10.0
164 pik3ca-related overgrowth syndrome 10.0
165 overgrowth syndrome 10.0
166 alcohol dependence 9.9
167 cardiac arrhythmia 9.9
168 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.9
169 hypertriglyceridemia, familial 9.9
170 chromosome 18p deletion syndrome 9.9
171 kleine-levin hibernation syndrome 9.9
172 motion sickness 9.9
173 schizophrenia 9.9
174 triiodothyronine receptor auxiliary protein 9.9
175 celiac disease 1 9.9
176 leprosy 3 9.9
177 lip prints 9.9
178 spondylometaphyseal dysplasia, sedaghatian type 9.9
179 rheumatic fever-related antigen 9.9
180 yemenite deaf-blind hypopigmentation syndrome 9.9
181 branchiootic syndrome 1 9.9
182 brittle bone disorder 9.9
183 sickle cell anemia 9.9
184 bone mineral density quantitative trait locus 3 9.9
185 psoriatic arthritis 9.9
186 mycobacterium tuberculosis 1 9.9
187 hypertensive nephropathy 9.9
188 myocardial infarction 9.9
189 major depressive disorder 9.9
190 alzheimer disease 17 9.9
191 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.9
192 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.9
193 mucopolysaccharidosis-plus syndrome 9.9
194 juvenile arthritis 9.9
195 angina pectoris 9.9
196 aspiration pneumonia 9.9
197 spastic cerebral palsy 9.9
198 rheumatic heart disease 9.9
199 oral squamous cell carcinoma 9.9
200 pain agnosia 9.9
201 colitis 9.9
202 angular cheilitis 9.9
203 recessive dystrophic epidermolysis bullosa 9.9
204 bone disease 9.9
205 mucositis 9.9
206 cycloplegia 9.9
207 sleeping sickness 9.9
208 trypanosomiasis 9.9
209 tonsillitis 9.9
210 common cold 9.9
211 osteomalacia 9.9
212 portal hypertension 9.9
213 tooth disease 9.9
214 hemiplegia 9.9
215 keratomalacia 9.9
216 chronic apical periodontitis 9.9
217 gestational diabetes 9.9
218 primary biliary cirrhosis 9.9
219 leukemia 9.9
220 secondary hyperparathyroidism 9.9
221 bell's palsy 9.9
222 submandibular gland disease 9.9
223 renal osteodystrophy 9.9
224 dementia 9.9
225 endemic goiter 9.9
226 tuberous sclerosis 9.9
227 hyperparathyroidism 9.9
228 kwashiorkor 9.9
229 eclampsia 9.9
230 facial neuralgia 9.9
231 facial paralysis 9.9
232 renal tubular acidosis 9.9
233 gonadal dysgenesis 9.9
234 root resorption 9.9
235 hypothyroidism 9.9
236 papilledema 9.9
237 aggressive periodontitis 9.9
238 alcohol use disorder 9.9
239 mental depression 9.9
240 keratosis 9.9
241 cheilitis 9.9
242 epilepsy 9.9
243 enthesopathy 9.9
244 autoimmune hepatitis 9.9
245 constipation 9.9
246 reflex epilepsy 9.9
247 dermatitis 9.9
248 bruxism 9.9
249 glomerulonephritis 9.9
250 lipid metabolism disorder 9.9
251 mood disorder 9.9
252 bone inflammation disease 9.9
253 plague 9.9
254 cellulitis 9.9
255 turner syndrome 9.9
256 skin disease 9.9
257 mouth disease 9.9
258 liver disease 9.9
259 systemic scleroderma 9.9
260 pustulosis of palm and sole 9.9
261 subacute bacterial endocarditis 9.9
262 epidermolysis bullosa dystrophica 9.9
263 nutritional deficiency disease 9.9
264 sleep disorder 9.9
265 pneumonia 9.9
266 bronchitis 9.9
267 overnutrition 9.9
268 juvenile rheumatoid arthritis 9.9
269 peptic ulcer disease 9.9
270 gastrointestinal system disease 9.9
271 placenta disease 9.9
272 pyridoxine deficiency anemia 9.9
273 herpes simplex 9.9
274 ulcerative colitis 9.9
275 eating disorder 9.9
276 molluscum contagiosum 9.9
277 psoriasis 9.9
278 neurofibroma 9.9
279 oral mucosa leukoplakia 9.9
280 aphthous stomatitis 9.9
281 refractive error 9.9
282 hypoglycemia 9.9
283 18p deletion syndrome 9.9
284 sickle cell disease 9.9
285 48,xyyy 9.9
286 chronic graft versus host disease 9.9
287 exercise-induced anaphylaxis 9.9
288 hansen's disease 9.9
289 lactate dehydrogenase deficiency 9.9
290 sutton disease 2 9.9
291 cryptogenic cirrhosis 9.9
292 depression 9.9
293 posttransplant acute limbic encephalitis 9.9
294 cleft lip and alveolus 9.9
295 glycogen storage disease due to lactate dehydrogenase deficiency 9.9
296 cranial neuralgia 9.9
297 inherited epidermolysis bullosa 9.9
298 teeth hard tissue disease 9.9 TUFT1 STATH ENAM DSPP DMBT1 AMELX

Comorbidity relations with Dental Caries via Phenotypic Disease Network (PDN): (showing 12, show less)


Acute Apical Periodontitis Acute Cystitis
Acute Pericementitis Alzheimer Disease
Aortic Valve Disease 1 Deficiency Anemia
Familial Atrial Fibrillation Gingivitis
Heart Disease Periodontitis, Chronic
Periodontosis Protein-Energy Malnutrition

Graphical network of the top 20 diseases related to Dental Caries:



Diseases related to Dental Caries

Symptoms & Phenotypes for Dental Caries

UMLS symptoms related to Dental Caries:


snoring, halitosis

GenomeRNAi Phenotypes related to Dental Caries according to GeneCards Suite gene sharing:

26 (showing 5, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased hepcidin::fluc mRNA expression GR00253-A 9.43 AMBN AMELX DMBT1 LPO MUC5B TUFT1
2 Decreased viability GR00249-S 9.36 LTF TAS1R2
3 Decreased viability GR00381-A-1 9.36 LTF TAS1R2 TUFT1
4 Decreased viability GR00381-A-3 9.36 LTF TAS1R2 TUFT1
5 Decreased viability GR00402-S-2 9.36 LTF TAS1R2 TUFT1

Drugs & Therapeutics for Dental Caries

Drugs for Dental Caries (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 256, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sorbitol Approved Phase 4 50-70-4 5780
2
Ethanol Approved Phase 4 64-17-5 702
3
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
4
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 5311068 68602
5
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
6
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
7
Histamine Approved, Investigational Phase 4 51-45-6 774
8
Meperidine Approved Phase 4 57-42-1 4058
9
Hydroxyzine Approved Phase 4 68-88-2 3658
10
Iodine Approved, Investigational Phase 4 7553-56-2 807
11
Petrolatum Approved, Investigational Phase 4 8009-03-8
12
Imidacloprid Vet_approved Phase 4 105827-78-9 86418
13 Caseins Phase 4
14 Chelating Agents Phase 4
15 Adrenergic Agents Phase 4
16 Adrenergic Agonists Phase 4
17 Pharmaceutical Solutions Phase 4
18 Bifidobacterium Phase 4
19 Acidophilus Phase 4
20 Fluorophosphate Phase 4
21 Anti-Inflammatory Agents Phase 4
22 Sodium fluoride topical preparation Phase 4
23 Laxatives Phase 4
24 Cathartics Phase 4
25 Gastrointestinal Agents Phase 4
26 Adrenergic alpha-Agonists Phase 4
27 Fibrinolytic Agents Phase 4
28 Analgesics, Non-Narcotic Phase 4
29 Platelet Aggregation Inhibitors Phase 4
30 Cyclooxygenase Inhibitors Phase 4
31 Antipyretics Phase 4
32 Antirheumatic Agents Phase 4
33 Anti-Inflammatory Agents, Non-Steroidal Phase 4
34 Excitatory Amino Acid Antagonists Phase 4
35 Anesthetics, Dissociative Phase 4
36 Neurotransmitter Agents Phase 4
37 Anesthetics, General Phase 4
38 Dermatologic Agents Phase 4
39 Anesthetics, Intravenous Phase 4
40 Hypnotics and Sedatives Phase 4
41 Anti-Anxiety Agents Phase 4
42 Psychotropic Drugs Phase 4
43 GABA Modulators Phase 4
44 Analgesics Phase 4
45 Narcotics Phase 4
46 Histamine H1 Antagonists Phase 4
47 Histamine Antagonists Phase 4
48 Analgesics, Opioid Phase 4
49
Histamine Phosphate Phase 4 51-74-1 65513
50 Calcium, Dietary Phase 4
51 Hormones Phase 4
52
Calcium Nutraceutical Phase 4 7440-70-2 271
53 Cinnamon Approved Phase 3
54
Licorice Approved Phase 2, Phase 3
55
silver nitrate Approved, Investigational Phase 3 7761-88-8
56
acetic acid Approved Phase 3 64-19-7 176
57
Glucosamine Approved, Investigational Phase 3 3416-24-8 439213
58
Titanium dioxide Approved Phase 3 13463-67-7
59
Erythritol Experimental Phase 2, Phase 3 149-32-6, 2418-52-2 169019
60
Chitosan Experimental Phase 3 9012-76-4 71853
61 Antibodies Phase 3
62 Immunoglobulins, Intravenous Phase 3
63 Immunologic Factors Phase 3
64 Immunoglobulins Phase 3
65 Carbopol 940 Phase 2, Phase 3
66 Vaccines Phase 3
67 Sulfalene Phase 2, Phase 3
68 Eusol Phase 3
69 Sodium hypochlorite Phase 3
70 Coagulants Phase 3
71 Photosensitizing Agents Phase 3
72
Retinol acetate Phase 3 127-47-9 10245972
73 Hypolipidemic Agents Phase 3
74
Chitin Phase 3 1398-61-4 444514
75 Lipid Regulating Agents Phase 3
76 Anticholesteremic Agents Phase 3
77 Sunscreening Agents Phase 3
78 Radiation-Protective Agents Phase 3
79 Antimetabolites Phase 3
80 Fluorides Phase 3
81 Protective Agents Phase 3
82
Doxycycline Approved, Investigational, Vet_approved Phase 2 564-25-0 54671203
83 sodium fluoride Approved Phase 2 7681-49-4
84
Phenylephrine Approved Phase 2 59-42-7 6041
85
Pseudoephedrine Approved Phase 2 90-82-4 7028
86
Ephedrine Approved Phase 2 299-42-3 9294
87
Oxymetazoline Approved, Investigational Phase 2 1491-59-4 4636
88
Tetracaine Approved, Vet_approved Phase 2 94-24-6 5411
89 Complement System Proteins Phase 2
90 Nigella Phase 2
91 Aloe Phase 2
92 6-chloro-2-(1-piperazinyl)pyrazine Phase 2
93 Serotonin Receptor Agonists Phase 2
94 Stevia Phase 2
95
Stevioside Phase 2 57817-89-7 548198
96 Vasodilator Agents Phase 2
97 Bacteriocins Phase 1, Phase 2
98 Polymethyl Methacrylate Phase 2
99 Fluorides, Topical Phase 2
100 Listerine Phase 2
101 Respiratory System Agents Phase 2
102 Sympathomimetics Phase 2
103 Anesthetics, Local Phase 2
104 Carticaine Phase 2
105 Nasal Decongestants Phase 2
106 Vasoconstrictor Agents Phase 2
107
Serotonin Investigational, Nutraceutical Phase 2 50-67-9 5202
108
Heparin Approved, Investigational Phase 1 9005-49-6 46507594 772
109
Calcium carbonate Approved, Investigational Phase 1 471-34-1
110
Lidocaine Approved, Vet_approved Phase 1 137-58-6 3676
111
Epinephrine Approved, Vet_approved Phase 1 51-43-4 5816
112
Racepinephrine Approved Phase 1 329-65-7 838
113 Grape Approved Phase 1
114 calcium heparin Phase 1
115 Adrenergic beta-Agonists Phase 1
116 Anti-Asthmatic Agents Phase 1
117 Bronchodilator Agents Phase 1
118 Vitremer Phase 1
119 Cholinergic Agents Phase 1
120 Tolonium Chloride Phase 1
121 Epinephryl borate Phase 1
122 Mydriatics Phase 1
123 Antioxidants Phase 1
124 Grape Seed Extract Phase 1
125 Anti-Bacterial Agents Phase 1
126
Fentanyl Approved, Illicit, Investigational, Vet_approved 437-38-7 3345
127
Cisatracurium Approved 96946-41-7
128
Nitrous oxide Approved, Vet_approved 10024-97-2 948
129
Peppermint oil Approved, Investigational 8006-90-4
130
Peppermint Approved
131
Propofol Approved, Investigational, Vet_approved 2078-54-8 4943
132
Sevoflurane Approved, Vet_approved 28523-86-6 5206
133
Clove Approved 84961-50-2
134
Nicotine Approved 54-11-5 942 89594
135
Vancomycin Approved 1404-90-6 14969 441141
136
Cefaclor Approved 53994-73-3 51039 40958
137
Ciprofloxacin Approved, Investigational 85721-33-1 2764
138
Metronidazole Approved 443-48-1 4173
139
Mannitol Approved, Investigational 69-65-8 6251 453
140
Methylphenidate Approved, Investigational 113-45-1 4158
141
Sodium citrate Approved, Investigational 68-04-2
142
Hydrogen peroxide Approved, Vet_approved Early Phase 1 7722-84-1 784
143
Hydrocortisone Approved, Vet_approved 50-23-7 5754
144
Hydrocortisone acetate Approved, Vet_approved 50-03-3
145
Iron Approved, Experimental 15438-31-0, 7439-89-6 27284 23925
146
Thymol Approved 89-83-8 6989
147
Ketorolac Approved 66635-83-4, 74103-06-3 3826
148
Cefuroxime Approved 55268-75-2 5479529 5361202
149
Atracurium Approved, Experimental, Investigational 64228-79-1 47319
150
Dopamine Approved 51-61-6, 62-31-7 681
151
Coal tar Approved 8007-45-2
152
Progesterone Approved, Vet_approved 57-83-0 5994
153
tannic acid Approved 1401-55-4
154
Benzocaine Approved, Investigational 94-09-7, 1994-09-7 2337
155
Methylene blue Approved, Investigational 61-73-4
156 Tangerine Approved
157
Povidone Approved 9003-39-8
158
Povidone-iodine Approved 25655-41-8
159
Hyaluronic acid Approved, Vet_approved 9004-61-9 53477741
160
Silicon Approved, Investigational 7440-21-3 4082203
161
Salicylic acid Approved, Investigational, Vet_approved 69-72-7 338
162
Terbutaline Approved 23031-25-6 5403
163
Papain Approved 9001-73-4
164
Eugenol Approved 97-53-0 3314
165
Zinc Approved, Investigational 7440-66-6 32051
166
Zinc oxide Approved 1314-13-2
167
Chlorhexidine Approved, Vet_approved 55-56-1 9552079 2713